Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
4.870
-0.020 (-0.41%)
Jul 10, 2025, 4:00 PM - Market closed
Terns Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts that cover Terns Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $15.63, which forecasts a 220.94% increase in the stock price over the next year. The lowest target is $7.5 and the highest is $20.
Price Target: $15.63 (+220.94%)
Analyst Consensus: Buy
* Price targets were last updated on May 13, 2025.
Analyst Ratings
The average analyst rating for Terns Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Maintains $26 → $15 | Buy | Maintains | $26 → $15 | +208.01% | May 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $20 | Buy | Reiterates | $20 | +310.68% | Apr 21, 2025 |
| William Blair | William Blair | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 28, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $20 | Buy | Reiterates | $20 | +310.68% | Dec 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $17 → $20 | Buy | Maintains | $17 → $20 | +310.68% | Dec 4, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.22
from -1.12
EPS Next Year
-1.36
from -1.22
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.16 | -1.25 | -1.44 | ||
| Avg | -1.22 | -1.36 | -1.57 | ||
| Low | -1.35 | -1.50 | -1.86 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.